INTRATUMORAL CORRELATION OF MULTIPLEX IMMUNOFLUORESCENCE AND 89ZR-CREFMIRLIMAB BERDOXAM IMMUNOPET IN RECURRENT GBM PATIENTS TREATED WITH NEOADJUVANT ANTI-PD-1+/- ANTI-CTLA-4 THERAPY

被引：0
|
作者：
Markus, Lauren [1 ]
Sun, Lu [1 ]
Hugo, Willy [1 ]
Van den Abbeele, Annick D. [2 ]
Wen, Patrick [3 ]
Prins, Robert [4 ]
机构：
[1] Univ Calif Los Angeles, Los Angeles, CA USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA
[4] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA USA
来源：
NEURO-ONCOLOGY | 2023年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IMMU-38
引用
收藏
页数：1
相关论文
共 42 条
  • [1] NEOADJUVANT ANTI-PD-1 AND ANTI-CTLA-4 COMBINATION THERAPY INDUCED INTRATUMORAL IMMUNOLOGIC ALTERATIONS IN RECURRENT GBM PATIENTS
    Markus, Lauren
    Wen, Patrick
    Sun, Lu
    Hugo, Willy
    Prins, Robert
    NEURO-ONCOLOGY, 2024, 26
  • [2] Brief Communication on Pathologic Assessment of Persistent Stable Metastatic Lesions in Patients Treated With Anti-CTLA-4 or Anti-CTLA-4+Anti-PD-1 Therapy
    Buchbinder, Elizabeth. I. I.
    Pfaff, Kathleen. L. L.
    Turner, Madison. M. M.
    Manos, Michael
    Ouyang, Olivia
    Ott, Patrick. A. A.
    Giobbie-Hurder, Anita
    Rodig, Scott. J. J.
    Hodi, F. Stephen
    JOURNAL OF IMMUNOTHERAPY, 2023, 46 (05) : 192 - 196
  • [3] Intratumoral CD16± Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy
    Lee, Hansol
    Ferguson, Angela L.
    Quek, Camelia
    Vergara, Ismael A.
    daSilva, Ines Pires
    Allen, Ruth
    Gide, Tuba Nur
    Conway, Jordan W.
    Koufariotis, Lambros T.
    Hayward, Nicholas K.
    Waddell, Nicola
    Carlino, Matteo S.
    Menzies, Alexander M.
    Saw, Robyn P. M.
    Shklovskaya, Elena
    Rizos, Helen
    Lo, Serigne
    Scolyer, Richard A.
    V. Long, Georgina
    Palendira, Umaimaintha
    Wilmott, James S.
    CLINICAL CANCER RESEARCH, 2023, 29 (13) : 2513 - 2524
  • [4] Resolution of tissue signatures of therapy response in patients with recurrent GBM treated with neoadjuvant anti-PD1
    Lu, Yue
    Ng, Alphonsus H. C.
    Chow, Frances E.
    Everson, Richard G.
    Helmink, Beth A.
    Tetzlaff, Michael T.
    Thakur, Rohit
    Wargo, Jennifer A.
    Cloughesy, Timothy F.
    Prins, Robert M.
    Heath, James R.
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [5] Resolution of tissue signatures of therapy response in patients with recurrent GBM treated with neoadjuvant anti-PD1
    Yue Lu
    Alphonsus H. C. Ng
    Frances E. Chow
    Richard G. Everson
    Beth A. Helmink
    Michael T. Tetzlaff
    Rohit Thakur
    Jennifer A. Wargo
    Timothy F. Cloughesy
    Robert M. Prins
    James R. Heath
    Nature Communications, 12
  • [6] Clinical and Molecular Heterogeneity in Patients with Innate Resistance to Anti-PD-1+/- Anti-CTLA-4 Immunotherapy in Metastatic Melanoma Reveals Distinct Therapeutic Targets
    Gide, Tuba N.
    Pires da Silva, Ines
    Quek, Camelia
    Ferguson, Peter M.
    Batten, Marcel
    Shang, Ping
    Ahmed, Tasnia
    Menzies, Alexander M.
    Carlino, Matteo S.
    Saw, Robyn P. M.
    Thompson, John F.
    Scolyer, Richard A.
    Long, Georgina V.
    Wilmott, James S.
    CANCERS, 2021, 13 (13)
  • [7] Seasonal patterns of toxicity in melanoma patients treated with combination anti-PD-1 and anti-CTLA-4 immunotherapy
    Rogiers, Aljosja
    Dimitriou, Florentia
    Lobon, Irene
    Harvey, Catriona
    Vergara, Ismael A.
    da Silva, Ines Pires
    Lo, Serigne N.
    Scolyer, Richard A.
    Carlino, Matteo S.
    Menzies, Alexander M.
    Long, Georgina V.
    EUROPEAN JOURNAL OF CANCER, 2024, 198
  • [8] Recurrent malignant melanoma of the uterine cervix treated with anti-PD-1 antibodies and anti-CTLA-4 antibodies: A case report
    Sone, Kenbun
    Kukita, Asako
    Masui, Yuri
    Yamada, Daisuke
    Shinozaki-Ushiku, Aya
    Kawata, Akira
    Taguchi, Ayumi
    Miyamoto, Yuichiro
    Tanikawa, Michihiro
    Iriyama, Takayuki
    Tsuruga, Tetsushi
    Osuga, Yutaka
    MOLECULAR AND CLINICAL ONCOLOGY, 2022, 16 (03)
  • [9] Immune cell dynamics of patients and mice with hepatocellular carcinoma treated with anti-PD-L1 plus anti-CTLA-4 combination therapy
    Myojin, Yuta
    Ruf, Benjamin
    Benmebarek, Mohamed-Reda
    Bauer, Kylynda
    Trehan, Rajiv
    Coffman, Kelley
    Ma, Chi
    Monge, Cecilia B.
    Xie, Changqing
    Greten, Tim
    CANCER RESEARCH, 2023, 83 (07)
  • [10] Differences in immune profiles of metastatic melanoma patients treated with anti-CTLA-4 and anti-PD-1 combined immunotherapy.
    Gide, Tuba Nur
    Quek, Camelia
    Madore, Jason
    Menzies, Alexander M.
    Dent, Rebecca
    Carlino, Matteo S.
    Guminski, Alex
    Saw, Robyn
    Thompson, John F.
    Wilmott, James S.
    Scolyer, Richard A.
    Long, Georgina V.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
12345